Author: Zech

The IoT Use Case Adoption Report 2024 is part of IoT Analytics’ ongoing research into IoT in general. The information presented in this report is based on extensive surveys of IoT end users across manufacturing, healthcare, retail and other industries. Its purpose is to inform other market participants about the current state of IoT use case adoption among businesses. Evolution of IoT Use Cases in 2021 and Beyond IoT efforts are becoming more successful, but the payback period is longer: the majority of IoT projects now have a positive ROI, up 13 percentage points compared to 2021. However, the share…

Not long ago, it was thought that Sony’s VR headset for PlayStation, PSVR2, would support PC VR. Soon after, Sony officially announced that this was the case, and that the PSVR2 PC adapter would be released in August. Now, the PSVR2 app has appeared on Steam, giving us a glimpse of how PSVR2 will work with PC VR. The PSVR2 app is required if you want to set up and use your headset with Steam. It also helps keep your PSVR2 headset and controller firmware up to date. The app lists the release date as August 6th, one day before…

Dana Calacci cares about data analytics, but even more so, she cares about the people it impacts. Or, as Calacci’s webpage states, “I study how data management and analytics impact community governance. Currently, I focus on how algorithmic management is changing the realities of work, how data management and participatory design can help create a new future of work, and the data rights of platform workers.” In an article in the July issue of IEEE Spectrum, Calacci offered an example of a kind of cautionary tale that leads to an inspiring conclusion. But along the way, Caracci also hinted at…

For AI to be fully integrated into consumers’ daily lives, end-user devices must be able to process AI workloads rather than relying solely on cloud computing. On-device AI reduces costs and latency, improves personalization and privacy, and enables real-time processing, all of which are essential for bringing AI to everyday applications and use cases. As a result, edge AI, which is closely related to the Internet of Things (IoT), is expected to continue to gain momentum. Edge AI is spreading across a variety of applications in IoT and consumer devices, including smartphones, wearables, headsets, drones, industrial technology, and automobiles. It…

Samsara Inc. (NYSE:IOT – Get Free Report) CEO Sanjit Biswas sold 84,150 shares of the company’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $38.06, for a total value of $3,202,749.00. Following the completion of the sale, the CEO now directly owns 1,190,149 shares of the company’s stock, valued at approximately $45,297,070.94. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink . Sanjit Biswas has also recently made the following transactions: On Tuesday, July 16th, Sanjit Biswas sold 59,112 shares of…

California-based pharmaceutical company BioMarin Pharmaceuticals (Nasdaq: BMRN) announced that the U.S. Food and Drug Administration has approved an expanded indication for Brineura (cerliponase alfa).This approval expands the approved use of Brineura to include children of all ages with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), regardless of symptoms.Previously, Brineura was approved to treat symptomatic children aged 3 years and older with late-infantile CLN2 disease. This article is available to registered users only. To continue reading, please sign up for free. Your free trial will give you access to one week of exclusive features, interviews, roundups and commentary from some of…

HTC has released a trailer for its new VR headset on the HTC Vive YouTube channel. While no information has been released and the headset itself hasn’t been properly revealed, it appears that specs for the new headset have already been revealed on social media.HTC is no newcomer to VR: While the Meta Quest 3 and Apple Vision Pro have dominated the VR news cycle lately, the company also makes some very powerful (and expensive) VR headsets. The trailer only hints at the potential of the new headset, nothing more. | Video credit — HTCVR hardware analyst Bradley Lynch appears…

Massachusetts-based HBSS Connect has acquired Israeli blockchain startup Colu, Investing.com has learned. The acquisition creates new opportunities to connect the traditional transportation market with the rapidly expanding blockchain-based payment systems. HBSS Connect is the company behind the transportation platform QRyde. Colu has been active in the blockchain space since 2014. The company’s digital wallet app was launched in early 2017 and is currently operational in cities including Tel Aviv, Haifa, East London and Liverpool, serving over 200,000 users and supporting transactions for 2,000 local businesses. The blockchain startup has already raised significant investments from companies such as IDB Development Corporation…

July 25, 2024July 25, 2024 Finance Minister Nirmala Sitharaman announced that the government will set up a Rs 1,000 crore venture capital fund for investments in India’s space economy. The move aims to expand India’s space economy five-fold over the next decade. The fund is expected to support space start-ups and encourage greater private sector participation. The initiative is expected to enhance India’s position in the global space market and attract domestic and international investments. The Economic Survey highlighted that Agnikul Cosmos, Chennai, will set up its first private launch pad and mission control centre…

Lausanne-based neurodegenerative disease specialist AC Immune SA and its commercialization partner Janssen Pharmaceuticals Inc/J&J have received Fast Track designation from the US Food and Drug Administration (FDA) for their phosphorylated-tau-targeted Alzheimer’s disease vaccine ACI-35.030/JNJ-2056, providing the opportunity to expedite development and market approval in the US. The FDA designation has led to a potential pivotal trial, the ReTain Phase 2b proof-of-concept study, which has just started enrolling asymptomatic patients and is expected to produce results in 2029. According to Andrea Pfeiffer, PhD, CEO of AC Immune, a previous Phase Ib/IIa study has demonstrated target specificity for ACI-35.030//JNJ-205, derived from AC…